Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, November 03, 2005 8:52:00 AM
Thu Nov 3, 2005 08:36 AM ET
Nov 3 (Reuters) - Syneron Medical Ltd. (ELOS.O: Quote, Profile, Research) on Thursday said it appointed its Chief Financial Officer David Schlachet as chief executive officer, replacing Moshe Mizrahy.
A company spokesperson said Mizrahy, who has been associated with the company since its inception in 2000, resigned, but did not give any reason.
However, Mizrahy will stay on Syneron board for a short period, the spokesperson said.
In a news release, the company also said it appointed Shimon Eckhouse as active chairman. (Reporting by Sunil Mathew Paul in Bangalore and Steven Scheer in Jerusalem)
http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh94357_2005-11-03_13-36-12_bng...
Dubi
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM